ERBB2 and breast cancer: Since a few decades ago, many gene-expression profiling studies of breast cancer have revealed the existence of four major subtypes differing markedly in prognosis: luminal-A, luminal-B, HER2-amplified, and basal-like [6], prevalence of which varies by racial/ethnic groups [7].